...
首页> 外文期刊>Biotechnology and Bioengineering >An ultra scale-down characterization of low shear stress primary recovery stages to enhance selectivity of fusion protein recovery from its molecular variants
【24h】

An ultra scale-down characterization of low shear stress primary recovery stages to enhance selectivity of fusion protein recovery from its molecular variants

机译:低切应力初级回收阶段的超比例缩减表征,可增强融合蛋白从其分子变异中回收的选择性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Fusion proteins offer the prospect of new therapeutic products with multiple functions. The primary recovery is investigated of a fusion protein consisting of modified E2 protein from hepatitis C virus fused to human IgG1 Fc and expressed in a Chinese hamster ovary (CHO) cell line. Fusion protein products inevitably pose increased challenge in preparation and purification. Of particular concerns are: (i) the impact of shear stress on product integrity and (ii) the presence of product-related contaminants which could prove challenging to remove during the high resolution purification steps. This paper addresses the use of microwell-based ultra scale-down (USD) methods to develop a bioprocess strategy focused on the integration of cell culture and cell removal operations and where the focus is on the use of operations which impart low shear stress levels even when applied at eventual manufacturing scale. An USD shear device was used to demonstrate that cells exposed to high process stresses such as those that occur in the feed zone of a continuous non-hermetic centrifuge resulted in the reduction of the fusion protein and also the release of glycosylated intracellular variants. In addition, extended cell culture resulted in release of such variants. USD mimics of low shear stress, hydrohermetic feed zone centrifugation and of depth filtration were used to demonstrate little to no release during recovery of these variants with both results verified at pilot scale. Furthermore, the USD studies were used to predict removal of contaminants such as lipids, nucleic acids, and cell debris with, for example, depth filtration delivering greater removal than for centrifugation but a small (~10%) decrease in yield of the fusion protein. These USD observations of product recovery and carryover of contaminants were also confirmed at pilot scale as was also the capacity or throughput achievable for continuous centrifugation or for depth filtration. The advantages are discussed of operating a lower yield cell culture and a low shear stress recovery process in return for a considerably less challenging purification demand.
机译:融合蛋白为具有多种功能的新型治疗产品提供了前景。研究了一种融合蛋白的初步回收,该融合蛋白由与人类IgG1 Fc融合并在中国仓鼠卵巢(CHO)细胞系中表达的丙型肝炎病毒修饰的E2蛋白组成。融合蛋白产品不可避免地在制备和纯化中带来越来越大的挑战。特别需要注意的是:(i)剪切应力对产品完整性的影响,以及(ii)产品相关污染物的存在,在高分辨率纯化步骤中很难去除。本文探讨了基于微孔的超小型化(USD)方法的发展,以开发一种生物过程策略,该策略专注于细胞培养和细胞去除操作的整合,并且重点在于使用即使在施加低剪切应力水平下的操作以最终的制造规模应用时。使用USD剪切装置来证明暴露于高过程压力的细胞,例如发生在连续非密封离心机进料区的细胞,导致融合蛋白的减少以及糖基化细胞内变体的释放。另外,延长的细胞培养导致这些变体的释放。低剪切应力,水密进料区离心和深度过滤的美元模拟被用来证明在这些变体的回收过程中几乎没有释放,且两个结果均在中试规模上得到了验证。此外,USD研究还用于预测脂质,核酸和细胞碎片等污染物的去除,例如,深层过滤的去除率要高于离心分离,但融合蛋白的收率下降幅度很小(约10%) 。这些对USD产品回收和污染物残留的USD观察结果也已在中试规模上得到了证实,对于连续离心或深层过滤所能达到的容量或通量也得到了证实。讨论了操作低产量细胞培养物和低剪切应力回收过程的优点,以换取相当少的挑战性纯化需​​求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号